1. Biopsy rate and nonalcoholic steatohepatitis (NASH) in patients with nonalcoholic fatty liver disease (NAFLD). (2nd June 2020) Authors: Gerhardt, Florian; Petroff, David; Blank, Valentin; Böhlig, Albrecht; van Bömmel, Florian; Wittekind, Christian; Berg, Thomas; Karlas, Thomas; Wiegand, Johannes Journal: Scandinavian journal of gastroenterology Issue: Volume 55:Number 6(2020) Page Start: 706 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Iberogast-Induced Acute Liver Failure—Reexposure and In Vitro Assay Support Causality. (August 2019) Authors: Gerhardt, Florian; Benesic, Andreas; Tillmann, Hans L.; Rademacher, Sebastian; Wittekind, Christian; Gerbes, Alexander L.; Henker, Robert; Berg, Thomas; Maidhof, Hans-Peter; Trauer, Heiner; Wiegand, Johannes Journal: American journal of gastroenterology Issue: Volume 114:Number 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Integrated visualisation for supporting decision-making in engineering processes, based on JT. (19th January 2011) Authors: Eigner, Martin; Gerhardt, Florian; Langlotz, Martin; Nem, Fabrice Mogo Journal: International journal of product lifecycle management Issue: Volume 5:Number 1(2011) Page Start: 37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. What are the risks of second medical use and dosing regimens in pharmaceutical patenting?. (September 2014) Authors: Kanz, Christine; Gerhardt, Florian Journal: Pharmaceutical patent analyst Issue: Volume 3:Number 5(2014) Page Start: 481 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗